- Report
- May 2023
- 162 Pages
Global
From €3363EUR$3,528USD£2,873GBP
€3957EUR$4,150USD£3,381GBP
- Report
- May 2023
- 162 Pages
Global
From €3363EUR$3,528USD£2,873GBP
€3957EUR$4,150USD£3,381GBP
- Report
- February 2022
- 395 Pages
Global
From €3432EUR$3,600USD£2,933GBP
- Report
- April 2023
- 233 Pages
Global
From €3432EUR$3,600USD£2,933GBP
- Report
- February 2023
- 100 Pages
Global
From €2622EUR$2,750USD£2,240GBP
- Report
- October 2023
- 88 Pages
Global
From €3500EUR$3,932USD£3,095GBP
- Report
- August 2021
- 88 Pages
Global
From €3200EUR$3,595USD£2,830GBP
- Report
- January 2022
- 114 Pages
Global
From €4290EUR$4,500USD£3,666GBP
- Report
- July 2021
- 259 Pages
Global
From €3539EUR$3,712USD£3,024GBP
- Book
- February 2022
- 496 Pages
The Human Milk Oligosaccharides (HMOs) market is a segment of the Vitamins and Dietary Supplements industry. HMOs are a type of prebiotic found in human breast milk, and are believed to have a range of health benefits. They are used in a variety of products, including infant formula, dietary supplements, and functional foods.
HMOs are gaining popularity due to their potential to improve gut health, boost immunity, and reduce the risk of certain diseases. They are also being studied for their potential to improve cognitive development in infants.
The HMOs market is driven by increasing awareness of the health benefits of HMOs, as well as the growing demand for infant formula and dietary supplements. The market is expected to grow in the coming years, as more research is conducted on the potential health benefits of HMOs.
Some companies in the Human Milk Oligosaccharides market include Abbott Nutrition, Nestle, Danone, FrieslandCampina, and Mead Johnson Nutrition. Show Less Read more